EP1214341A4 - Dendritic cell membrane protein fire - Google Patents

Dendritic cell membrane protein fire

Info

Publication number
EP1214341A4
EP1214341A4 EP00962083A EP00962083A EP1214341A4 EP 1214341 A4 EP1214341 A4 EP 1214341A4 EP 00962083 A EP00962083 A EP 00962083A EP 00962083 A EP00962083 A EP 00962083A EP 1214341 A4 EP1214341 A4 EP 1214341A4
Authority
EP
European Patent Office
Prior art keywords
cell membrane
membrane protein
dendritic cell
protein fire
fire
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00962083A
Other languages
German (de)
French (fr)
Other versions
EP1214341A1 (en
Inventor
Irina Caminschi
Stephane Alain Vandenabeele
Mark Dexter Wright
Kenneth Douglas Shortman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Walter and Eliza Hall Institute of Medical Research
Original Assignee
Walter and Eliza Hall Institute of Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Walter and Eliza Hall Institute of Medical Research filed Critical Walter and Eliza Hall Institute of Medical Research
Publication of EP1214341A1 publication Critical patent/EP1214341A1/en
Publication of EP1214341A4 publication Critical patent/EP1214341A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4615—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464499—Undefined tumor antigens, e.g. tumor lysate or antigens targeted by cells isolated from tumor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP00962083A 1999-09-09 2000-09-11 Dendritic cell membrane protein fire Withdrawn EP1214341A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPQ272899 1999-09-09
AUPQ2728A AUPQ272899A0 (en) 1999-09-09 1999-09-09 Dendritic cell membrane protein fire
PCT/AU2000/001083 WO2001018047A1 (en) 1999-09-09 2000-09-11 Dendritic cell membrane protein fire

Publications (2)

Publication Number Publication Date
EP1214341A1 EP1214341A1 (en) 2002-06-19
EP1214341A4 true EP1214341A4 (en) 2003-04-23

Family

ID=3816898

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00962083A Withdrawn EP1214341A4 (en) 1999-09-09 2000-09-11 Dendritic cell membrane protein fire

Country Status (5)

Country Link
EP (1) EP1214341A4 (en)
JP (1) JP2003515316A (en)
AU (1) AUPQ272899A0 (en)
CA (1) CA2384405A1 (en)
WO (1) WO2001018047A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2367822A (en) * 2000-06-19 2002-04-17 Smithkline Beecham Corp CD97 polypeptides

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006698A1 (en) * 1998-07-30 2000-02-10 Human Genome Sciences, Inc. 98 human secreted proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006698A1 (en) * 1998-07-30 2000-02-10 Human Genome Sciences, Inc. 98 human secreted proteins

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CAMINSCHI I ET AL: "Molecular cloning of F4/80-like-receptor, a seven-span membrane protein expressed differentially by dendritic cell and monocyte-macrophage subpopulations.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD.: 1950) UNITED STATES 1 OCT 2001, vol. 167, no. 7, 1 October 2001 (2001-10-01), pages 3570 - 3576, XP002230957, ISSN: 0022-1767 *
MCKNIGHT ET AL: "The EGF-TM7 family: Unusual structures at the leukocyte surface", JOURNAL OF LEUKOCYTE BIOLOGY, FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL, US, vol. 63, no. 3, March 1998 (1998-03-01), pages 271 - 280, XP002118911, ISSN: 0741-5400 *
See also references of WO0118047A1 *

Also Published As

Publication number Publication date
EP1214341A1 (en) 2002-06-19
CA2384405A1 (en) 2001-03-15
JP2003515316A (en) 2003-05-07
AUPQ272899A0 (en) 1999-09-30
WO2001018047A1 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
HK1043876A1 (en) Solid gel membrane
AU6906800A (en) Membrane associated proteins
AU3706700A (en) Positively charged membrane
EP1228547A4 (en) Fuel cell system
AU2455301A (en) Electrochemical cell system
AU2002352137A8 (en) Fuel cell system
AU5003600A (en) Charged membrane
GB9904905D0 (en) Cells
IL133494A0 (en) Isolated dendritic cell membrane protein genes
EP1411572A4 (en) Fuel cell system
EP1180042A4 (en) Model membrane systems
AU1154802A (en) Single cell electroporation
AU2002364382A8 (en) Fuel cell system
HUP9800134A3 (en) Separator with membrane
AU4077099A (en) Cell signaling proteins
GB9821706D0 (en) Membrane structure
AU2203901A (en) Microporous membrane
AU2001267724A1 (en) Electrochemical cell
AU4391900A (en) Electrochemical cell
AU4081900A (en) Porous membrane
AU2001286205A1 (en) Novel dendritic cell wall membrane and use thereof
EP1210208A4 (en) Membrane probing system
AU5208500A (en) Flow cell
EP1128451A4 (en) Cell
EP1214341A4 (en) Dendritic cell membrane protein fire

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020409

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RES

RIC1 Information provided on ipc code assigned before grant

Ipc: 7G 01N 33/54 B

Ipc: 7A 61K 39/395 B

Ipc: 7C 12Q 1/24 B

Ipc: 7C 07K 14/47 B

Ipc: 7C 07K 14/435 A

Ipc: 7C 12N 5/16 B

Ipc: 7A 61P 37/06 B

Ipc: 7C 12N 5/22 B

Ipc: 7C 07H 21/04 B

A4 Supplementary search report drawn up and despatched

Effective date: 20030310

17Q First examination report despatched

Effective date: 20031001

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050215